Form 4: Invus Public Equities Sells 1.6 Million Shares of Scholar Rock Holding Corp

Invus Public Equities, L.P. sold 1.6 million shares of Scholar Rock Holding Corp at a price of $41.65 per share on December 10, 2024.

Summary

• Invus Public Equities, L.P. sold 1,600,000 shares of Scholar Rock Holding Corp common stock on December 10, 2024.
• The sale price was $41.65 per share.
• Following the transaction, Invus Public Equities, L.P. directly owns 9,250,005 shares of Scholar Rock Holding Corp.
• The reporting entities include Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, and Raymond Debbane.
• These entities are related through ownership and management structures.
• Each reporting person disclaims beneficial ownership of securities held by other reporting persons, except to the extent of their pecuniary interest.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the large sale of shares by a major shareholder, which could indicate a lack of confidence in the company's future prospects and potentially lead to downward pressure on the stock price.

Negatives

• Invus Public Equities, L.P., a significant shareholder, has reduced its stake in Scholar Rock Holding Corp by selling 1.6 million shares.

Risks

• The sale of a large block of shares by a major shareholder could potentially put downward pressure on the stock price.
• The interconnectedness of the reporting entities could lead to further coordinated sales.

Management Comments

• Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons, except to the extent of such reporting person's pecuniary interest therein.

Industry Context

This transaction is a routine disclosure of a significant shareholder's trading activity, which is common in the biotech industry. Such sales can sometimes influence market sentiment and stock price.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies, including those in the biotech sector like Scholar Rock Holding Corp.
• Similar filings are made by major shareholders of companies like Regeneron Pharmaceuticals and Biogen when they trade shares, providing transparency to the market.

Stakeholder Impact

• Shareholders may react negatively to the sale, potentially leading to a decrease in the stock price.
• The sale could impact market perception of the company's stability and future prospects.

Key Dates

Keywords

Scholar Rock Holding Corp, Invus Public Equities, share sale, stock transaction, beneficial ownership, Form 4, SEC filing